EpiCast Report: Insomnia Epidemiology Forecast to 2023
www.bigmarketresearch.com
Acquired (Autoimmune) Hemolytic Anemia
Report Description GlobalData epidemiologists forecast that the total prevalent cases of acute insomnia in the 7MM will increase from 121,799,911 total prevalent cases in 2013, to 130,482,156 total prevalent cases in 2023 at an Annual Growth Rate (AGR) of 0.71%. GlobalData epidemiologists forecast an increase in the total prevalent cases of chronic insomnia (not fulfilling DSM-IV criteria) in the 7MM from 62,982,390 total prevalent cases in 2013, to 67,471,957 total prevalent cases in 2023 at an AGR of 0.71%. The 7MM had an estimated 23,690,040 total prevalent cases of chronic primary insomnia in 2013 and the number of total prevalent cases is expected to increase to 25,378,728 by 2023, at an AGR of 0.71%. GlobalData epidemiologists forecast that the total prevalent cases of chronic secondary insomnia in the 7MM will increase from 53,697,425 total prevalent cases in 2013, to 57,525,122 total prevalent cases in 2023 at an AGR of 0.71%.
Read complete report here @ http://www.bigmarketresearch.com/epicast-report-insomnia-epidemiology-forecastto-2023-market
Acquired (Autoimmune) Hemolytic Anemia
Report Description Insomnia is a highly prevalent condition; approximately one third of the general population presents with some degree of insomnia.
GlobalData epidemiologists used comprehensive country-specific data from populationbased studies published in peer-reviewed journal articles to arrive at a meaningful, indepth analysis and forecast for the total prevalent cases of acute insomnia, chronic insomnia (not fulfilling DSM-IV criteria), chronic primary insomnia, and chronic secondary insomnia in the 7MM, based on the DSM-IV criteria. For all the 7MM, the total prevalent cases of acute insomnia, chronic insomnia (not fulfilling DSM-IV criteria), chronic primary insomnia, and chronic secondary insomnia were segmented by age and sex, which facilitates an understanding of the distribution of the disease within the population and informs strategies to improve the management of the disease. Furthermore, the forecast methodology is consistent across each of the 7MM, thereby allowing for a meaningful comparison of the forecast total prevalent cases among each market. Get enquire about report here @ http://www.bigmarketresearch.com/report-enquiry/178077
Acquired (Autoimmune) Hemolytic Anemia
Table Of Contents 1. Introduction • Catalyst • Related Reports • Upcoming Related Reports 2. Europe Refining Industry • • • • • • • •
Disease Background Risk Factors and Comorbidities Global Trends Forecast Methodology Sources Used Sources Not Used Forecast Assumptions and Methods Epidemiological Forecast for Acute Insomnia (2013-2023)
Acquired (Autoimmune) Hemolytic Anemia
Table Of Contents 3. Appendix
• • • • •
Bibliography About the Authors Epidemiologists Reviewers Global Director of Therapy Analysis and Epidemiology
Get complete TOC @ http://www.bigmarketresearch.com/epicast-report-insomniaepidemiology-forecast-to-2023-market
Acquired (Autoimmune) Hemolytic Anemia
Report Description
Reasons to buy • Develop business strategies by understanding the trends shaping and driving the global insomnia market. • Quantify patient populations in the global insomnia market to improve product design, pricing, and launch plans. • Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for insomnia therapeutics in each of the markets covered.
FOR MORE DETAILS Visit us at : http://www.bigmarketresearch.com/epicast-report-insomniaepidemiology-forecast-to-2023-market
Stay With Us:
TELEPHONE: +1 (855) 711-1555 E-MAIL: help@bigmarketresearch.com
5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States